India
UK
Africa

Choose another country or region to see content specific to your location

COVID-19

Home > News

Covaxin gets emergency use nod for kids: Here's what experts have to say

IPE Global | News | October 13, 2021 IST

Covaxin gets emergency use nod for kids: Here's what experts have to say

As national drugs regulator’s subject expert committee approves the use of Bharat Biotech's Covaxin in children between the age-group of 2-18, health experts have welcomed the development saying it will be beneficial for children and help them resume normal lives but added that there is a need to establish its efficacy globally so that the children are not subject to restrictive measures when they travel abroad.

Click here to know more..



Related News


No related news found.